Bayesian Capital Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,882
Closed -$3.33M 744
2025
Q2
$3.33M Buy
+20,882
New +$3.41M 0.53% 43
2024
Q4
Sell
-10,800
Closed -$1.87M 915
2024
Q3
$1.87M Buy
+10,800
New +$1.83M 0.22% 137
2024
Q1
Sell
-52,840
Closed -$7.74M 1036
2023
Q4
$7.74M Buy
52,840
+15,900
+43% +$2.35M 0.82% 15
2023
Q3
$5.39M Sell
36,940
-37,300
-50% -$5.7M 0.62% 31
2023
Q2
$11.3M Buy
+74,240
New +$11.2M 1.21% 7
2023
Q1
Sell
-7,500
Closed -$1.14M 1026
2022
Q4
$1.14M Buy
7,500
+5,200
+226% +$729K 0.17% 159
2022
Q3
$290K Buy
+2,300
New +$327K 0.06% 421
2021
Q3
Sell
-29,700
Closed -$4.01M 496
2021
Q2
$4.01M Sell
29,700
-100
-0.3% -$13.5K 1.05% 16
2021
Q1
$4.04M Buy
29,800
+15,800
+113% +$2.06M 0.93% 15
2020
Q4
$1.95M Buy
+14,000
New +$1.96M 0.51% 43
2020
Q2
Sell
-10,400
Closed -$1.14M 721
2020
Q1
$1.14M Sell
10,400
-39,900
-79% -$4.79M 0.25% 98
2019
Q4
$6.28M Buy
+50,300
New +$6.15M 1.07% 9
2019
Q2
Sell
-63,011
Closed -$6.56M 650
2019
Q1
$6.56M Buy
63,011
+49,500
+366% +$4.82M 1.26% 5
2018
Q4
$1.24M Buy
+13,511
New +$1.21M 0.25% 109
2017
Q4
Sell
-17,371
Closed -$1.58M 679
2017
Q3
$1.58M Buy
+17,371
New +$1.58M 0.38% 71
2017
Q2
Sell
-13,800
Closed -$1.24M 558
2017
Q1
$1.24M Sell
13,800
-19,000
-58% -$1.68M 0.59% 22
2016
Q4
$2.76M Buy
+32,800
New +$2.8M 0.68% 2

Other funds holding PG

Bayesian Capital Management's PG Position: Q3 2025 in Review

Bayesian Capital Management sold out of Procter & Gamble (PG) in Q3 2025, closing a stake of 20,882 shares — an estimated $3.33M sold.

Bayesian Capital Management first reported a position in PG in Q4 2016 and held it in 17 quarters. The position peaked at $11.3M in Q2 2023. 3,893 funds tracked by Wall St. Rank hold PG as of Q3 2025.

  • Bayesian Capital Management reported no remaining Procter & Gamble position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 20,882 Procter & Gamble shares in Q3 2025, an estimated $3.33M.
  • Bayesian Capital Management first reported a position in Procter & Gamble in Q4 2016 and held it in 17 quarters.
  • Bayesian Capital Management's Procter & Gamble position peaked at $11.3M in Q2 2023.
  • 3,893 funds tracked by Wall St. Rank held Procter & Gamble as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.